NCT03360968

Brief Summary

Rationale Studies show that about a third of all postoperative complications are due to cardiovascular reasons. Furthermore it was shown that more than 50% of postoperative deaths are associated with severe cardiovascular incidents. After surgical interventions seriously ill patients are transferred to intensive care units and mechanically ventilated. However there is not much evidence about the impact of mechanical ventilation on the cardiovascular system and cardiovascular complications. Artificial mechanical ventilation greatly differs from physiological breathing. In contrast to physiological negative pressure ventilation of th lung, mechanical positive pressure ventilation can cause ventilator induced lung injuries. Furthermore a significant deterioration of lung-heart-interaction during mechanical ventilation is known. Relevance Mechanical ventilation leads to a decreased heartrate-variability, which has to be understood as increased stress on the cardiovascular system. Recently, a new ventilation mode called "variable pressure support ventilation" (VPSV) also known as "noisy pressure support ventilation". This new ventilation mode is similar to the ventilator mode "spontaneous-continuous positive airway pressure/pressure support" (SPN-CPAP), which is often used in a intensive care unit routine. Though VPSV differs through varying applicated pressure support and therefore tidal volumes. Therefore the new ventilation mode rather imitates physiological situation, since tidal volumes vary in physiological breathing, which has positive impact on heart-lung-interaction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 4, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

February 6, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

April 8, 2020

Status Verified

April 1, 2020

Enrollment Period

2.8 years

First QC Date

November 22, 2017

Last Update Submit

April 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • HF components

    High frequency (HF) components of heartrate-variability in ms²

    2 hours

Secondary Outcomes (3)

  • SDNN

    2 hours

  • HF-LF-ratio

    2 hours

  • Tidal volumes

    2 hours

Other Outcomes (3)

  • pH

    At minute 5, 55, 65 and 115 of the measurement

  • PaO2

    At minute 5, 55, 65 and 115 of the measurement

  • PaCO2

    At minute 5, 55, 65 and 115 of the measurement

Study Arms (2)

Treatment A-B

EXPERIMENTAL

Patient is treated with 1 hour SPN-CPAP/PS followed by 1 hour of Variable-PS ventilation mode

Procedure: Variable-PSProcedure: SPN-CPAP/PS

Treatment B-A

EXPERIMENTAL

Patient is treated with 1 hour Variable-PS followed by 1 hour of SPN-CPAP/PS ventilation mode

Procedure: SPN-CPAP/PSProcedure: Variable-PS

Interventions

Variable-PSPROCEDURE

Variable-PS mode switched on for 1 hour

Treatment A-B
SPN-CPAP/PSPROCEDURE

SPN-CPAP/PS mode switched on for 1 hour

Treatment A-BTreatment B-A

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients undergoing therapy at an ICU; patients intubated and ventilated using SPN-CPAP/PS ventilator mode; patients with sinus rhythm in electrocardiogram

You may not qualify if:

  • patients with active heart pace maker / defibrillator; patients with absent sinus rhythm in electrocardiogram; patients with known severe disease of autonomous nervous system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna

Vienna, 1090, Austria

Location

Study Officials

  • Maximlian Schnetzinger, BSc

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 22, 2017

First Posted

December 4, 2017

Study Start

February 6, 2018

Primary Completion

December 1, 2020

Study Completion

December 31, 2020

Last Updated

April 8, 2020

Record last verified: 2020-04

Locations